Interleukin-8 Receptors CXCR1 and CXCR2 Are Not Expressed by Endothelial Colony-forming Cells.


Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
04 2021
Historique:
accepted: 08 11 2020
pubmed: 14 11 2020
medline: 4 3 2022
entrez: 13 11 2020
Statut: ppublish

Résumé

Endothelial colony-forming cells (ECFCs) are human vasculogenic cells described as potential cell therapy product and good candidates for being a vascular liquid biopsy. Since interleukin-8 (IL-8) is a main actor in senescence, its ability to interact with ECFCs has been explored. However, expression of CXCR1 and CXCR2, the two cellular receptors for IL-8, by ECFCs remain controversial as several teams published contradictory reports. Using complementary technical approaches, we have investigated the presence of these receptors on ECFCs isolated from cord blood. First, CXCR1 and CXCR2 were not detected on several clones of cord blood- endothelial colony-forming cell using different antibodies available, in contrast to well-known positive cells. We then compared the RT-PCR primers used in different papers to search for the presence of CXCR1 and CXCR2 mRNA and found that several primer pairs used could lead to non-specific DNA amplification. Last, we confirmed those results by RNA sequencing. CXCR1 and CXCR2 were not detected in ECFCs in contrary to human-induced pluripotent stem cell-derived endothelial cells (h-iECs). In conclusion, using three different approaches, we confirmed that CXCR1 and CXCR2 were not expressed at mRNA or protein level by ECFCs. Thus, IL-8 secretion by ECFCs, its effects in angiogenesis and their involvement in senescent process need to be reanalyzed according to this absence of CXCR-1 and - 2 in ECFCs.Graphical Abstract.

Identifiants

pubmed: 33185837
doi: 10.1007/s12015-020-10081-y
pii: 10.1007/s12015-020-10081-y
pmc: PMC8337095
mid: NIHMS1727431
doi:

Substances chimiques

CXCR2 protein, human 0
Receptors, Interleukin-8A 0
Receptors, Interleukin-8B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

628-638

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR069038
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128452
Pays : United States

Références

Stem Cells. 2013 Aug;31(8):1657-68
pubmed: 23629812
Cell Mol Life Sci. 2011 Sep;68(17):2811-30
pubmed: 21479594
Blood. 2013 Jan 10;121(2):403-15
pubmed: 23074273
Front Med (Lausanne). 2018 Oct 23;5:295
pubmed: 30406106
FASEB J. 2000 Oct;14(13):2055-64
pubmed: 11023990
Int Immunopharmacol. 2013 Jun;16(2):261-7
pubmed: 23597430
J Thromb Haemost. 2019 Jul;17(7):1190-1194
pubmed: 31119878
Adv Exp Med Biol. 2019;1201:215-237
pubmed: 31898789
Sci Adv. 2020 Jul 24;6(30):eaba7606
pubmed: 32832668
Stem Cell Rev Rep. 2019 Aug;15(4):590-600
pubmed: 30879244
J Cell Mol Med. 2009 Aug;13(8B):2534-2546
pubmed: 18657231
Circulation. 2005 Sep 13;112(11):1618-27
pubmed: 16145003
Biomol Detect Quantif. 2017 Nov 22;14:19-28
pubmed: 29201647
Sci Rep. 2017 Feb 23;7:43057
pubmed: 28230162
Cytokine. 1995 Apr;7(3):267-72
pubmed: 7543779
Angiogenesis. 2015 Jul;18(3):347-59
pubmed: 26026674
Genome Biol. 2014;15(12):550
pubmed: 25516281
Stem Cells Dev. 2017 Jun 15;26(12):912-931
pubmed: 28418782
Bioinformatics. 2012 Oct 15;28(20):2678-9
pubmed: 22914218
Circ Res. 2008 Jul 18;103(2):194-202
pubmed: 18556575
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10137-42
pubmed: 24982174
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9233-7
pubmed: 3480540
Immunity. 2000 Feb;12(2):121-7
pubmed: 10714678
Science. 1991 Sep 13;253(5025):1278-80
pubmed: 1840701
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):625-633
pubmed: 30084946
Science. 1991 Sep 13;253(5025):1280-3
pubmed: 1891716
Theranostics. 2019 Jul 9;9(18):5332-5346
pubmed: 31410218
Blood. 2007 Mar 1;109(5):1801-9
pubmed: 17053059
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell Biol Int. 2011 Mar;35(3):201-8
pubmed: 20958269
J Immunol. 2000 Nov 1;165(9):5269-77
pubmed: 11046061
Stem Cell Rev Rep. 2018 Feb;14(1):82-91
pubmed: 28980146
Physiol Rev. 2013 Oct;93(4):1743-802
pubmed: 24137021
Stem Cell Rev Rep. 2020 Apr;16(2):357-368
pubmed: 31898801
Science. 1992 Dec 11;258(5089):1798-801
pubmed: 1281554
Exp Gerontol. 2006 May;41(5):474-81
pubmed: 16626901
Science. 1995 Apr 21;268(5209):447-8
pubmed: 7716553
Cytokine. 1999 Sep;11(9):704-12
pubmed: 10479407
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96
pubmed: 24954210
Angiogenesis. 2019 May;22(2):325-339
pubmed: 30607696

Auteurs

Adeline Blandinières (A)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Service d'Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Xuechong Hong (X)

Department of Cardiac Surgery, Boston Children's Hospital, Boston, MA, USA.
Department of Surgery, Harvard Medical School, Boston, MA, USA.

Aurélien Philippe (A)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Service d'Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Ivan Bièche (I)

Department of Genetics, Université de Paris and Pharmacogenomics Unit, Institut Curie, Paris, France.

Sophie Vacher (S)

Department of Genetics, Université de Paris and Pharmacogenomics Unit, Institut Curie, Paris, France.

Elisa Rossi (E)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.

Grégoire Detriche (G)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.

Nicolas Gendron (N)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Service d'Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Pascale Gaussem (P)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Service d'Hématologie, AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France.

Coralie L Guerin (CL)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Plateforme de cytométrie, Institut Curie, F-75006, Paris, France.

Juan M Melero-Martin (JM)

Department of Cardiac Surgery, Boston Children's Hospital, Boston, MA, USA.
Department of Surgery, Harvard Medical School, Boston, MA, USA.
Harvard Stem Cell Institute, Cambridge, MA, USA.

David M Smadja (DM)

Innovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France. david.smadja@aphp.fr.
Service d'Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier), AH-HP, Georges Pompidou European Hospital, F-75015, Paris, France. david.smadja@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH